Log in to save to my catalogue

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2001068107

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

About this item

Full title

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2018-02, Vol.554 (7691), p.249-254

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Measurement of human plasma amyloid-β biomarkers using immunoprecipitation coupled with mass spectrometry reliably predicts individual brain amyloid-β status and has potential clinical utility.
Plasma marker predicts amyloid-β pathology in the brain
Alzheimer's disease is characterized by the deposition of amyloid-β (Aβ) peptide in the brain....

Alternative Titles

Full title

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2001068107

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2001068107

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/nature25456

How to access this item